Chemical Structure : NUCC-0227579
Catalog No.: PC-27236Not For Human Use, Lab Use Only.
NUCC-0227579 (C79) is a potent, first-in-class CD73 PROTAC degrader with DC50 of 0.32 uM, degrades CD73 via the VHL E3 ligase-dependent proteasomal and lysosomal pathways.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NUCC-0227579 (C79) is a potent, first-in-class CD73 PROTAC degrader with DC50 of 0.32 uM, degrades CD73 via the VHL E3 ligase-dependent proteasomal and lysosomal pathways.
C79 eliminated CD73 at the cell surface and intracellular compartments across multiple human cancer cell lines, abolishing nucleotidase activity and more effectively reversing adenosine-mediated immunosuppression than enzymatic inhibitors.
C79 enhanced NF-κB/NFAT signaling, increased IFN-γ and TNF-α production, and promoted human CD8+ T cell activation and proliferation.
C79 impaired tumor cell metabolic fitness, proliferation, migration, and adhesion through non-nucleotidase-dependent mechanisms.
C79 significantly suppressed tumor growth while enhancing antitumor immune responses humanized NSG mouse models of TNBC.
| M.Wt | 450.89 | |
| Formula | C24H15ClN8 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Ping Xie, et al. J Med Chem. 2026 Jul 9;69(13):15630-15652.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright